Anthem Blue Cross Blue Shield of California prior authorization code reference, page 70

Check eligibility for free

No account required. Sign a BAA to see plan details, coordination of benefits and more

Source code lookup

Each row links an imported source code to its service or category label. Check the original document for the complete plan scope, review type and qualifications.

Source code index

Imported source codes and labels; verify the complete review requirements in the original document
CodeDescriptionSource
Q5143Adalimumab-adbm (Cyltezo)California PPO Prior Authorization List, Pg 187 Original policy
Q5134Natalizumab-sztn (Tyruko)California PPO Prior Authorization List, Pg 187 Original policy
Q5144Adalimumab-aacf (Idacio)California PPO Prior Authorization List, Pg 187 Original policy
Q5145Adalimumab-afzb (Abrilada)California PPO Prior Authorization List, Pg 187 Original policy
Q5147Aflibercept-ayyh (Pavblu)California PPO Prior Authorization List, Pg 187 Original policy
Q5149Aflibercept-abzv (Enzeevu)California PPO Prior Authorization List, Pg 187 Original policy
Q5150Aflibercept-mrbb (Ahzantive)California PPO Prior Authorization List, Pg 187 Original policy
Q5151Eculizumab-aagh (Epysqi)California PPO Prior Authorization List, Pg 187 Original policy
Q5152Eculizumab-aeeb (Bkemv)California PPO Prior Authorization List, Pg 187 Original policy
Q5153Aflibercept-yszy (Opuviz)California PPO Prior Authorization List, Pg 187 Original policy
Q5154Omalizumab - igec (Omlyclo)California PPO Prior Authorization List, Pg 187 Original policy
Q5155Aflibercept-jbvf (Yesafili)California PPO Prior Authorization List, Pg 187 Original policy
Q5164Ustekinumab-hmny (Starjemza)California PPO Prior Authorization List, Pg 187 Original policy
Q5168Ranibizumab-leyk (Nufymco)California PPO Prior Authorization List, Pg 187 Original policy
Q5170Aflibercept-boav (Eydenzelt)California PPO Prior Authorization List, Pg 187 Original policy
Q9996Ustekinumab-ttwe (Pyzchiva)California PPO Prior Authorization List, Pg 187 Original policy
Q9997Ustekinumab-ttwe (Pyzchiva IV)California PPO Prior Authorization List, Pg 187 Original policy
Q9998Ustekinumab-aekn (Selarsdi)California PPO Prior Authorization List, Pg 187 Original policy
Q9999Ustekinumab-aauz (Otulfi)California PPO Prior Authorization List, Pg 187 Original policy
S9560Home injectable therapy; hormonal therapy (e.g., leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diemCalifornia PPO Prior Authorization List, Pg 187 Original policy
J0565Bezlotoxumab (Zinplava)California PPO Prior Authorization List, Pg 188 Original policy
J0641Levoleucovorin (Fusilev)California PPO Prior Authorization List, Pg 188 Original policy
J0642Levoleucovorin (Khapzory)California PPO Prior Authorization List, Pg 188 Original policy
J0881Darbepoetin Alfa (Aranesp)California PPO Prior Authorization List, Pg 188 Original policy
J0882Darbepoetin Alfa (Aranesp)California PPO Prior Authorization List, Pg 188 Original policy
J0896Luspatercept (Reblozyl)California PPO Prior Authorization List, Pg 188 Original policy
J0897Denosumab (Prolia, Xgeva)California PPO Prior Authorization List, Pg 188 Original policy
J1442Filgrastim (Neupogen)California PPO Prior Authorization List, Pg 188 Original policy
J1447Tbo-Filgrastim (Granix)California PPO Prior Authorization List, Pg 188 Original policy
J1449Eflapegrastim-xnst (Rolvedon)California PPO Prior Authorization List, Pg 188 Original policy
J1459Immune globulin, IV, non-lyophilized (Privigen)California PPO Prior Authorization List, Pg 188 Original policy
J1551Immuno globulin (Cutaquig)California PPO Prior Authorization List, Pg 189 Original policy
J1553Immune globulin intravenous, human-dira (Yimmugo)California PPO Prior Authorization List, Pg 189 Original policy
J1554Immune Globulin (Human) IV (Asceniv)California PPO Prior Authorization List, Pg 189 Original policy
J1555Immune Globulin (Cuvitru)California PPO Prior Authorization List, Pg 189 Original policy
J1556Immune Globulin (Bivigam)California PPO Prior Authorization List, Pg 189 Original policy
J1557Immune Globulin (Gammaplex)California PPO Prior Authorization List, Pg 189 Original policy
J1558Immune Globulin (Human)-klhw (Xembify)California PPO Prior Authorization List, Pg 189 Original policy
J1559Immune Globulin (Human) Subcutaneous (Hizentra)California PPO Prior Authorization List, Pg 189 Original policy
J1561Immune Globulin (Human) IV or Subcutaneous (Gamunex- C/Gammaked)California PPO Prior Authorization List, Pg 189 Original policy
J1566Immune Globulin (Human) IV (Gammagard SD)California PPO Prior Authorization List, Pg 189 Original policy
J1568Immune Globulin (Human) IV (Octagam)California PPO Prior Authorization List, Pg 189 Original policy
J1569Immune Globulin (Gammagard Liquid, Gammagard Liquid ERC)California PPO Prior Authorization List, Pg 189 Original policy
J1572Immune Globulin (Human) IV (Flebogamma)California PPO Prior Authorization List, Pg 189 Original policy
J1575Immune Globulin (Human) IV (HyQvia)California PPO Prior Authorization List, Pg 189 Original policy
J1576Immune Globulin (Human) IV (Panzyga)California PPO Prior Authorization List, Pg 189 Original policy
J1930Lanreotide (Somatuline Depot)California PPO Prior Authorization List, Pg 190 Original policy
J1932Lanreotide (cipla)California PPO Prior Authorization List, Pg 190 Original policy
J2353Octreotide, depot form (Sandostatin LAR depot)California PPO Prior Authorization List, Pg 190 Original policy
J2354Octreotide (Sandostatin)California PPO Prior Authorization List, Pg 190 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.